Pharmacology: Pharmacodynamics/Pharmacokinetics: PERMIXON belongs to the group of medicines used in benign prostatic hypertrophy and acts at the prostatic level improving the symptoms associated with benign prostatic hypertrophy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education